16 Sep, EOD - Indian

Nifty IT 36212.15 (0.86)

SENSEX 82380.69 (0.73)

Nifty Bank 55147.6 (0.47)

Nifty 50 25239.1 (0.68)

Nifty Smallcap 100 18298.35 (0.95)

Nifty Midcap 100 58799.55 (0.54)

Nifty Pharma 22264.55 (0.30)

Nifty Next 50 69000.75 (0.58)

16 Sep, EOD - Global

NIKKEI 225 44774.47 (-0.28)

HANG SENG 26438.51 (-0.03)

S&P 6684 (0.07)


Market Beat News

You are Here : Home > News > Market Beat News >

(11 Jul 2025, 14:52)

Marksans Pharma fixes record date for final dividend

Record date is 01 August 2025


Marksans Pharma has fixed 01 August 2025 as record date for determining eligibility of Members to receive final dividend for the financial year ended 31 March 2025. The final dividend, if approved at the AGM, will be paid, subject to deduction of tax at source, on or after 21 August 2025.
More News

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +